These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22059937)

  • 1. Treatment with levetiracetam in a patient with pervasive developmental disorders, severe intellectual disability, self-injurious behavior, and seizures: a case report.
    Deriaz N; Willi JP; Orihuela-Flores M; Galli Carminati G; Ratib O
    Neurocase; 2012; 18(5):386-91. PubMed ID: 22059937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of self-injury with phenytoin in a man with autism and intellectual disability: the role of frontal lobe seizures and catatonia.
    Coffey MJ
    J ECT; 2013 Mar; 29(1):e12-3. PubMed ID: 23422527
    [No Abstract]   [Full Text] [Related]  

  • 3. Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.
    Davanzo PA; King BH
    J Child Adolesc Psychopharmacol; 1996; 6(4):273-9. PubMed ID: 9231320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case.
    Díaz Negrillo A; Martín Del Valle F; González Salaices M; Prieto Jurczynska C; Carneado Ruiz J
    Neurologia; 2011 Jun; 26(5):285-90. PubMed ID: 21353345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic substitution of levetiracetam resulting in increased incidence of breakthrough seizures.
    Fitzgerald CL; Jacobson MP
    Ann Pharmacother; 2011 May; 45(5):e27. PubMed ID: 21521860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catatonia induced by levetiracetam.
    Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
    Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of levetiracetam on behavioral problems in pervasive developmental disorder children with epilepsy.
    Kanemura H; Sano F; Ohyama T; Sugita K; Aihara M
    Eur J Paediatr Neurol; 2014 Jul; 18(4):482-8. PubMed ID: 24703761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of self-injurious behaviour exhibited by individuals with autism spectrum disorder.
    Richman DM; Barnard-Brak L; Bosch A; Thompson S; Grubb L; Abby L
    J Intellect Disabil Res; 2013 May; 57(5):429-39. PubMed ID: 22998594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of self-injurious behaviors in adults with severe intellectual disabilities.
    Tureck K; Matson JL; Beighley JS
    Res Dev Disabil; 2013 Sep; 34(9):2469-74. PubMed ID: 23747938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis.
    Chatterjee A; Louis ED; Frucht S
    Mov Disord; 2002 May; 17(3):614-5. PubMed ID: 12112221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
    Friedman D; French JA
    Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam may favorably affect seizure outcome after temporal lobectomy.
    Jehi LE; Irwin AI; Kayyali H; Vadera S; Bingaman W; Najm I
    Epilepsia; 2012 Jun; 53(6):979-86. PubMed ID: 22462729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory Self-Injurious Behavior in Severe Intellectual Disability Responsive to Topiramate: A Case Report.
    Hamm B; Khokhar N; Jimenez XF
    Psychosomatics; 2017; 58(2):209-212. PubMed ID: 28189287
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonepileptic seizures under levetiracetam therapy.
    Ignatenco A; Arzy S; Ghika J; Genoud D; Kaplan PW; Groppa S; Seeck M
    Epilepsy Behav; 2010 Nov; 19(3):526-7. PubMed ID: 20934390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidal ideation in epilepsy and levetiracetam therapy.
    Mula M; Sander JW
    Epilepsy Behav; 2007 Aug; 11(1):130-2. PubMed ID: 17544331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
    Aeby A; Poznanski N; Verheulpen D; Wetzburger C; Van Bogaert P
    Epilepsia; 2005 Dec; 46(12):1937-42. PubMed ID: 16393159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status gelasticus associated with levetiracetam as add-on treatment.
    Pustorino G; Spano M; Sgro DL; Di Rosa G; Tricomi G; Bellantone D; Tortorella G
    Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-injurious behaviour in people with intellectual disability.
    Oliver C; Richards C
    Curr Opin Psychiatry; 2010 Sep; 23(5):412-6. PubMed ID: 20644478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.